Pnc Financial Services Group, Inc. Halozyme Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,130 shares of HALO stock, worth $492,289. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,130
Previous 9,708
5.95%
Holding current value
$492,289
Previous $464,000
25.43%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$950 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$692 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$326 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$210 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$198 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.51B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...